Fiala

Peptide library › Brain & nerves

NNZ-2591

In clinical trialsBrain & nerves

Experimental oral medicine studied for rare genetic brain conditions such as Phelan-McDermid and Angelman syndromes.

What people use it for

What NNZ-2591 does in the body

A synthetic version of cyclic glycine-proline, a natural molecule involved in regulating IGF-1 in the brain.

Strength of evidence

Limited: open-label Phase 2 studies reported improvements; a placebo-controlled Phase 3 trial is under way.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Liquid by mouth (in trials)

How long it lasts (half-life): Not well established in published data

Keep track of NNZ-2591 privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open NNZ-2591 in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Brain & nerves